APC Recommendations:

Eltrombopag(Revolade) for the treatment of thrombocytopenia in adult patients with chronic hepatitis C virus infection, where degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy.

The JPC agreed to support the attached East of England Priorities Advisory Committee (EoEPAC) Guidance Statement.

Full details available upon request – contact Medicines Optimisation team